BKDVBNY Mellon Dynamic Value ETF$34.57+0.66%
incl. div.
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
Holders:12
Total Value:$41,469,362
Total Shares:1,230,545
Institutional Ownership Trend
8 quarters
Holder Concentration
Across 12 13F filers
· Δ vs Jun 30, 2026
Top Holder
19.6%
−3.1 pts
Top 5
67.1%
+10.2 pts
Top 10
98.2%
+23.9 pts
HHI
1,202
Broadly held+303
Who Holds BKDV
Last 8 quarters through Sep 30, 2026 (filing window open)
Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory
records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book.
The quarter selector does not change this card.
Jun 30, 2026, the newest closed quarter:
96 filers,
like-for-like change +36.1%; actively managed books +41.1%; index-like books +1.7%.
Holder type
Share
Filers
Change
New
Exited
Registered adviser
39.5%
52
+25.1%
9
2
Exempt adviser
0.0%
1
new
1
0
Bank
19.2%
10
+12.7%
1
0
Broker-dealer
8.0%
1
+280.6%
0
0
Holding company
1.4%
3
+127.1%
2
0
Unknown
31.9%
29
+43.8%
1
1
Style
Share
Filers
Change
New
Exited
Index-like
9.5%
2
+1.7%
1
0
Systematic-like
0.0%
1
new
1
0
Concentrated
5.1%
22
+3.9%
4
1
Diversified active
85.4%
71
+44.1%
8
2
Not measured
0.0%
0
—
0
0
Unknown
0.0%
0
—
0
0
Turnover
Share
Filers
Change
New
Exited
Low turnover
92.9%
71
+40.0%
11
1
Medium turnover
5.9%
12
-0.8%
1
2
High turnover
0.1%
3
-28.5%
1
0
Unknown
1.0%
10
+6.1%
1
0
Not measured
0.0%
0
—
0
0
Holding horizon
Share
Filers
Change
New
Exited
Short horizon
0.7%
8
-0.7%
1
0
Medium horizon
26.6%
22
+48.3%
4
1
Long horizon
72.4%
63
+32.6%
8
2
Unknown
0.2%
3
+27.5%
1
0
Not measured
0.0%
0
—
0
0
13F book size
Share
Filers
Change
New
Exited
Under $1B
8.4%
37
+10.9%
6
1
$1B to $10B
15.7%
23
+15.6%
2
1
$10B to $100B
20.9%
23
+40.5%
4
0
$100B or more
55.0%
13
+46.9%
2
1
Not measured
0.0%
0
—
0
0
Client base
Share
Filers
Change
New
Exited
Individuals and high net worth
36.6%
48
+28.1%
9
1
Corporations
0.1%
1
-4.4%
0
0
Other investment advisers
2.3%
1
-3.2%
0
0
Other
0.5%
1
+2.7%
0
0
Diversified
0.0%
1
-44.0%
0
1
Pooled investment vehicles
0.0%
0
—
0
0
Unknown
60.5%
44
+44.4%
5
1
Private funds
Share
Filers
Change
New
Exited
Hedge funds
0.2%
2
+29.1%
1
2
Private equity funds
4.2%
6
+63.5%
2
0
Other private funds
2.1%
3
+9.6%
0
0
Private funds, type not stated
0.0%
1
-19.0%
0
0
No private funds
33.0%
41
+22.7%
7
0
Unknown
60.5%
43
+44.3%
4
1
Location
Share
Filers
Change
New
Exited
United States
100.0%
93
+36.1%
12
3
Outside the US
0.0%
3
+20456.5%
2
0
The Sep 30, 2026 filing window is still open, so its
bar shows only the filers that have filed so far.
How the mix is measured
Shares are 13F common shares restated to today's split basis; options and principal amounts are left out.
The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later
quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type
comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster
current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and
book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none
was. Actively managed books are those measured systematic-like, concentrated or diversified active.
Excluded 3 holders with no observed 2026-03-31 13F.
Quarterly Activity
vs Jun 30, 2026
New
0
Increased
11
Decreased
1
Sold Out
0
Unchanged
0
New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.
